Avandia Panel Rife with Conflict

Avandia Panel Rife with Conflict

The news of Avandia panelist Dr. Abraham Thomas confessing a potential conflict comes after another panelist Dr. David Capuzzi was discovered to be a paid speaker for GSK, the drug…

More in Health >
Avandia panel says diabetes drug should stay on market

Avandia panel says diabetes drug should stay on market

Shocker from the FDA advisory panel: it voted Avandia should stay on the market despite the fact it increases the risk for heart attack. Total vote count: 20 for continued…

More in News >
GlaxoSmithKline Spends $460 Million; Settles 10,000 Avandia Lawsuits

GlaxoSmithKline Spends $460 Million; Settles 10,000 Avandia Lawsuits

Updated:  The diabetes drug Avandia has been the subject of several lawsuits, claiming that the drug can cause heart attacks and strokes. Manufacturer GlaxoSmithKline Plc. Is the biggest drug maker…

More in Business >
FDA Seeks Avandia Decision

FDA Seeks Avandia Decision

This week a two day advisory committee is meeting to decide the fate of GlaxoSmithKline’s popular diabetes medication Avandia. This meeting is about the drug itself, as well as the…

More in Health >
Is Avandia Too Risky?

Is Avandia Too Risky?

The FDA has posted an in depth 700 page review of the once popular diabetes drug Avandia. This GlaxoSmithKline product was once a number one seller, however it has fallen…

More in News >